SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-049066
Filing Date
2023-04-24
Accepted
2023-04-24 16:53:33
Documents
1
Group Members
ABE INVESTMENTS LLCFOUNDERS FUND GROWTH MANAGEMENT, LLCFOUNDERS FUND GROWTH PRINCIPALS FUND, LPFOUNDERS FUND GROWTH, LPFOUNDERS FUND VII ENTREPRENEURS FUND, LPFOUNDERS FUND VII MANAGEMENT, LLCFOUNDERS FUND VII PRINCIPALS FUND, LPFOUNDERS FUND VII, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2313479d1_sc13da.htm SC 13D/A 108153
  Complete submission text file 0001104659-23-049066.txt   109965
Mailing Address 9200 SUNSET BOULEVARD SUITE 1110 WEST HOLLYWOOD CA 90069
Business Address 9200 SUNSET BOULEVARD SUITE 1110 WEST HOLLYWOOD CA 90069 323-990-2000
THIEL PETER (Filed by) CIK: 0001211060 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Subject) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91923 | Film No.: 23840720
SIC: 2834 Pharmaceutical Preparations